Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study) - PubMed

This study performed by GPs shows that LP-33 improves the quality of life of subjects with persistent AR who are currently being treated with an oral H1-antihistamine. Whereas nasal symptoms had not changed, ocular symptoms had consistently improved.分類：pmid:24569538, doi:10.1038/ejcn.2014.13, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, D J Costa, P Marteau, J Bousquet, Adult, Dietary Supplements*, Double-Blind Method, Endpoint Determination, Female, Histamine Antagonists / pharmacology, Humans, Lactobacillus*, Loratadine / therapeutic use, Male, Middle Aged, Patient Compliance, Pollen / adverse effects, Pollen / immunology, Probiotics / administration & dosage*, Quality of Life, Rhinitis, Allergic, Seasonal / drug therapy, Rhinitis, Allergic, Seasonal / immunology, Rhinitis, Allergic, Seasonal / therapy*, Seasons, Treatment Outcome, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE...